This application seeks to continue the postdoctoral training grant titled, Research Training Program for Medical Geneticists for years 11-15. The program's overall goal is to: provide a mentored career development experience for physician-scientists to perform basic/translational research, develop the skills and experience required to compete for federal funding, and to become academic leaders in medical genetics/genomics. The program's emphasis is on basic, translational and/or clinical research using the latest techniques to investigate the pathogenesis of monogenic and complex traits, and to translate these findings into improved diagnosis, prevention, and effective therapies. The Department of Genetics and Genomic Sciences, with >100 full-time primary faculty, serves as the focus for the integration of genetics and genomics in all areas of medicine at Mount Sinai. The training environment builds upon considerable genetic/genomic, cell and molecular biologic, and clinical expertise of faculty in our basic science and clinical Departments and Institutes. Strengths of our training program include: 1) an exceptional group of funded and experienced Research Mentors in multidisciplinary research programs; 2) our ABMGG-accredited Medical Genetics training programs; 3) didactic courses in genomics and translational research including MS and PhD programs, and in the Responsible Conduct of Research, and 4) an infrastructure of Shared Research Facilities (SRFs) including our Institute for Genomics and Multiscale Biology. Physician-scientist trainees chosen for this training program typically will have completed a residency in Medical Genetics. Our Medical Genetics residency programs provide a pipeline of potential candidates who have a commitment to a basic/ translational research career. Highly qualified medical geneticist and physician- scientist applicants from other residency training programs and underrepresented minority candidates also will be recruited. Trainees will be supported for a period of 2 to 3 years under the supervision of their chosen Research Mentor, and each trainee will have an appropriate Advisory Committee. Previous trainees from this program have successfully obtained academic and industry positions and have applied for/received private agency and federal funding. All trainees will focus on their research projects and participate in our weekly work-in progress conference, weekly Genetics/Genomics seminar series, and may take selected didactic courses or an MS degree. This training program will meet a critical need for well-trained geneticists who can translate advances in genetics/genomics and biotechnology into improved diagnosis, treatment, and prevention of human disease.

Public Health Relevance

The continuous advances in genetics and genomics have led to greater understanding of monogenic and common diseases and cancers, with the implicit prospects of their improved diagnosis and treatment. Physician-scientists trained in genetics/genomics are especially qualified to carry out research that will further combat these diseases. This training grant is designed to provide mentored research training to outstanding physician-geneticists so they may advance research, develop independent research careers, and potentially become future leaders in genetics/genomics and medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM082773-11
Application #
9417490
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Sledjeski, Darren D
Project Start
2008-07-01
Project End
2023-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Genetics
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Reiner, Jennifer; Pisani, Laura; Qiao, Wanqiong et al. (2018) Cytogenomic identification and long-read single molecule real-time (SMRT) sequencing of a Bardet-Biedl Syndrome 9 (BBS9) deletion. NPJ Genom Med 3:3
Schussler, Edith; Linkner, Rita V; Levitt, Jacob et al. (2018) Protein-losing enteropathy and joint contractures caused by a novel homozygous ANTXR2 mutation. Adv Genomics Genet 8:17-21
De Rubeis, Silvia; Siper, Paige M; Durkin, Allison et al. (2018) Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Mol Autism 9:31
Prasun, Pankaj; Chapel-Crespo, Cristel; Williamson, Amy et al. (2018) Skin lesions in a patient with Cobalamin C disease in poor metabolic control. J Inherit Metab Dis 41:279-280
Manheimer, Kathryn B; Richter, Felix; Edelmann, Lisa J et al. (2018) Robust identification of mosaic variants in congenital heart disease. Hum Genet 137:183-193
Ligsay, Andrew; Van Dijck, Anke; Nguyen, Danh V et al. (2017) A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. J Neurodev Disord 9:26
Siper, Paige M; De Rubeis, Silvia; Trelles, Maria Del Pilar et al. (2017) Prospective investigation of FOXP1 syndrome. Mol Autism 8:57
Shi, L; Webb, B D; Birch, A H et al. (2017) Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants. Clin Genet 91:599-604
Tanaka, Akemi J; Cho, Megan T; Willaert, Rebecca et al. (2017) De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism. Cold Spring Harb Mol Case Stud 3:
Soorya, Latha; Leon, Jill; Trelles, M Pilar et al. (2017) Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome. Clin Neuropsychol :1-30

Showing the most recent 10 out of 62 publications